US & Europe Orphan Drug Market: 817 Orphan Designated Drug in Clinical Development Phase in US & Europe Says "US & Europe Orphan Drug Pipeline" Report by PNS Pharma
Delhi (PRWEB) October 15, 2013 -- US & Europe will continue to dominate the global orphan drug market in terms of market sales and new orphan drug development in future. US has 507 orphan designated drug in clinical development phase as compare to 310 orphan designated drugs in Europe.
“US Orphan Drug Pipeline Analysis” & “Europe Orphan Drug Pipeline Analysis” research reports by PNS Pharma gives comprehensive insight on the various orphan designated drugs being developed for the treatment of rare disease in US & Europe. These two reports include comprehensive insight on all the orphan designated drugs being developed in various clinical phases in US & Europe. These two reports also enable pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the US & Europe Orphan Drug market based upon development process.
Following parameters for each drug profile in development phase are covered in “US Orphan Drug Pipeline Analysis” & “Europe Orphan Drug Pipeline Analysis” research report:
• Drug Profile Overview
• Alternate Names for Drug
• Active Indication
• Phase of Development
• Mechanism of Action
• Brand Name
• Patent Information
• Orphan Designation by Indication, Country & Organisation
• Country for Clinical Trial
• Owner / Originator/ Licensee/Collaborator
• Administrative Route
• Drug Class
• ATC Codes
US Orphan Drug Development Pipeline by Clinical Phase:
• Research: 4
• Preclinical: 54
• Phase-I: 68
• Phase-I/II: 62
• Phase-II: 169
• Phase-II/III: 15
• Phase-III: 93
• Preregistration: 28
• Registration: 18
• Marketed: 137
Europe Orphan Drug Development Pipeline by Clinical Phase:
• Preclinical: 29
• Phase-I: 25
• Phase-I/II: 37
• Phase-II: 100
• Phase-II/III: 13
• Phase-III: 79
• Preregistration: 18
• Registration: 9
• Marketed: 100
Report Web Link: “US Orphan Drug Pipeline Analysis” & “Europe Orphan Drugs Pipeline Analysis”
For Report Sample Contact:
Rajesh Sharma
Sr. Analyst (Drug Pipeline)
+91-11-47067990
Recently Published Drug Pipeline Reports:
- Global Cancer Vaccines Pipeline Analysis
- Global HIV Infection Pipeline Analysis
- Global Infertility Drug Pipeline Analysis
- Global Oncolytic Virus Therapy Pipeline Analysis
- Global DNA Vaccine Pipeline Analysis
- Global RNAi Drug Pipeline Analysis
- Global Cell Therapy Pipeline Analysis
- Gene Therapy Drug Pipeline Analysis
- Pancreatic Cancer Drug Pipeline Analysis
- Hepatitis C Drug Pipeline Analysis
- Malaria Disease Drug Pipeline Analysis
- Ovarian Cancer Pipeline Analysis
Upcoming Drug Pipeline Reports:
- Orphan Drugs for Cancer
- Type 1 Diabetes Drug
- Type 2 Diabetes Drug
- Global Monoclonal Antibodies (mAb) Pipeline
- Influenza A Virus Pipeline
- Breast Cancer Drug Pipeline
Rajesh Sharma, PNS Pharma, http://www.pnspharma.com/, +91-11-47067990, [email protected]
Share this article